Cognex files Form 144 to sell 60,010-option shares

Cognex Corporation submitted a Form 144 notice reporting proposed sales of common stock tied to a stock option exercise and restricted stock awards.

Rhea-AI Filing Summary

Cognex Corporation submitted a Form 144 notice reporting proposed sales of common stock tied to a stock option exercise and restricted stock awards. The filing lists a stock option exercise of 60,010 shares dated 05/11/2026 and restricted stock items of 1,945 shares (02/21/2026), 1,582 shares (02/18/2026), and 1,336 shares (02/20/2026).

Insights

Securities Compliance Analyst

Form 144 lists proposed insider sales tied to option exercise and recent restricted stock grants.

The filing records a stock option exercise sale of 60,010 shares dated 05/11/2026 and three restricted stock entries dated in February 2026. These items are typical disclosures required when an affiliate proposes to sell shares.

Cash‑flow treatment and whether sales were executed are not shown in the excerpt; subsequent filings or trading reports would show completed transactions.

Key Figures

Stock option exercise: 60,010 shares Restricted stock (02/21/2026): 1,945 shares Restricted stock (02/18/2026): 1,582 shares +2 more

5 metrics

Stock option exercise 60,010 shares sale listed dated 05/11/2026

Restricted stock (02/21/2026) 1,945 shares Restricted stock listed dated 02/21/2026

Restricted stock (02/18/2026) 1,582 shares Restricted stock listed dated 02/18/2026

Restricted stock (02/20/2026) 1,336 shares Restricted stock listed dated 02/20/2026

Broker-dealer named Morgan Stanley Smith Barney LLC listed in filer/broker section

Key Terms

Form 144, Stock Option Exercise, Restricted Stock

3 terms

Form 144 regulatory

"submitted a Form 144 notice reporting proposed sales of common stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Stock Option Exercise | Issuer | 60010 | 05/11/2026"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Restricted Stock | Issuer | 1945 | 02/21/2026"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CGNX report on Form 144?

The Form 144 reports proposed sales of common stock tied to an option exercise and restricted stock awards. It lists a stock option exercise of 60,010 shares dated 05/11/2026 and restricted stock items of 1,945; 1,582; and 1,336 shares dated in February 2026.

How many shares from a stock option exercise did CGNX list?

The filing lists a stock option exercise of 60,010 shares dated 05/11/2026. The excerpt states this as the security to be sold; execution or proceeds are not shown in the provided content.

What restricted stock amounts are included in the CGNX Form 144?

The Form 144 shows restricted stock entries of 1,945 shares (02/21/2026), 1,582 shares (02/18/2026), and 1,336 shares (02/20/2026). Each line is labeled "Restricted Stock" with the corresponding date and issuer designation.

Does the filing state who is brokering the sale for CGNX shares?

Yes. The excerpt names Morgan Stanley Smith Barney LLC Executive Financial Services with an address at 1 New York Plaza, New York, NY. The filing lists this broker-dealer in the "Securities To Be Sold" section of the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002131255
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COGNEX CORPORATION
SEC File Number	001-34218
Address of Issuer	One Vision Drive Natick MASSACHUSETTS 01760
Phone	(508) 650-3000
Name of Person for Whose Account the Securities are To Be Sold	MARK FENNELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	64873	4350032.80	166419451	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/11/2026	Stock Option Exercise	Issuer			60010	05/11/2026	Cash
Common	02/21/2026	Restricted Stock	Issuer			1945	02/21/2026	Not Applicable
Common	02/18/2026	Restricted Stock	Issuer			1582	02/18/2026	Not Applicable
Common	02/20/2026	Restricted Stock	Issuer			1336	02/20/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Fennell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)